16 Nov 2018 | 4:11 PM
 

AstraZeneca Pharma India Ltd. Share Price Live (BSE)
0

BSE Code: 506820 | NSE Symbol: ASTRAZEN
1,659.15
-12.50
(-0.74 %)
16 Nov 2018 | 04:01 PM
Change company
  • Open (Rs)
    1,677.25
  • Prev. close (Rs.)
    1,671.65
  • High (Rs.)
    1,696.05
  • Low (Rs.)
    1,651.00
  • 52W H (Rs.)
    1,960.00
  • 52W L (Rs.)
    920.00
  • Volume
    770
  • MCap (Rs in Cr.)
    4,147.88
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

News

17 Aug 2018 - 09:21:00-AstraZeneca Pharma India Limited (AZPIL) has said that it has received Import & Market permission fo...
22 Jun 2018 - 11:22:00-Shares of AstraZeneca Pharma India soared 5 per cent on the Bombay Stock Exchange after drug maker r...
22 Jun 2018 - 09:45:00-AstraZeneca Pharma India Limited (AZPIL) has said that it has received Import & Market permission fo...
22 May 2018 - 13:00:00-The company reported standalone net profit during the quarter stood at Rs 3...

Announcements

14-Nov-2018
AstraZeneca Pharma I - Financial Result Updates
13-Nov-2018
AstraZeneca Pharma I - Outcome Of The Board Meeting Held On Tuesday November 13 2018
29-Oct-2018
AstraZeneca Pharma I - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday N
18-Oct-2018
AstraZeneca Pharma I - Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulati
18-Oct-2018
AstraZeneca Pharma I - Shareholding for the Period Ended September 30 2018

Religare Research

15 Nov 2018 | 03:45 PM
Jamna Auto Industries (JAI) reported mixed set of numbers in Q2FY19. While revenue growth was strong...
15 Nov 2018 | 03:40 PM
APL Apollo tubes (APT) reported its Q2FY19 numbers which came in below our expectations. Net revenue...
15 Nov 2018 | 03:20 PM
Castrol India Ltd (CIL) reported in-line revenue growth of 7.6% YoY in Q3CY18, which was both volume...
15 Nov 2018 | 10:22 AM
• Gold prices hold steady as dollar eases • Natural Gas Prices Soar To 9-Year Highs As Cold Forecast...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,32,431 50.40 21.24 0.09
4,32,431 50.40 254.89 0.09
4,32,431 50.40 25.26 0.09
4,32,431 50.40 267.83 0.09
4,32,431 50.40 25.92 0.09

Shareholding Pattern

       
Promotors75.00%
Mutual Funds/UTI5.44%
FI/Banks0.06%
Insurance0.06%
FII0.49%
Government0.00%
Others4.32%

Peer Group

Company Intraday Graph
 Merck Ltd.
3,027.35(1.36)
3302
 Ajanta Pharma Ltd.
1,119.65(3.36)
3790
 Dr. Lal Pathlabs Ltd.
829.00(-3.81)
17140
 Ipca Laboratories Ltd.
755.00(0.25)
3488

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Astrazeneca Pharma India Ltd.-28.60-51.15536.50
NIFTY(S&P CNX)169.70-702.85-119.65
BSE SENSEX592.06-2,206.40-86.78
BSE 500271.21-1,111.09-602.33

Corporate Details

Key Personal
Gagan Singh Bedi
Managing Director
Gregory David Emil Mueller
Non Executive Director
Ian John Parish
Non Executive Director
Key Address
Registered Office
Avishkar Off Bellary Road Hebbal,Bangalore,Karnataka

Tel:080-23622020 23622021 23622022 67748000, Fax:080-23622015

comp.secy@astrazeneca.com
http://www.astrazenecaindia.com
Registrar Office
Integrated Enterprises (India) Ltd.
Add. :No.30 Ramana Residency 4th Cross Sampige Road Malleswaram